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The activity of  argininosuccinate synthetase (E.C. 6.3.4.5), a urea cycle enzyme, 
was measured in cultured human lymphocytes using a new radioactive assay. 
Control cells had a maximum specific activity of  15.7+_8.7 nmoles per hour 
per milligram of  protein and an apparent Km for citrulline of 2 × 10 -4 M, 
whereas cells derived from a patient with citrullinemia had no detectable 
activity. A nutritional variant, selected out of  the citrullinemic lymphocyte 
population by ability to grow in citrulline, had a maximum specific activity 
of  10.7++_3.8 nmoles/hr/mg and an apparent K m for citrulline of 2 x 10 -e M. 
These measurements confirm the observation that citrullinemia is associated 
with a defect in argininosuccinate synthetase activity and provide further 
evidence that citrullinemia is expressed in cultured lymphocytes. The emergence 
of a nutritional variant with a partial defect in argininosuccinate synthetase 
enzyme suggests that this citrullinemic patient has a heterogeneous population 
of cells, some totally defective and others only partially defective in arginino- 
succinate synthetase. The new activity assay is described in detail. 
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INTRODUCTION 
Spector and Bloom (1973) have shown that the hereditary urea cycle disorder 
citrullinemia is expressed in lymphocytes, that is, the defect responsible for 
this disease, although primarily a defect in liver argininosuccinate synthetase 
activity (McMurray et al., 1963; Morrow et al., 1967; Mohyuddin et al., 
1967), is reflected in the patient's cultured lymphocytes. In this article, we 
describe a direct assay for argininosuccinate synthetase activity in cultured 
lymphocyte lines from the same citrullinemic patient, as well as in several 
control lines. 
We report here a new microassay for argininosuccinate synthetase in 
crude cell homogenates. Our assay measures the amount of 14C-arginino- 
succinate made from 14C-aspartate. The urea cycle steps pertinent to our 
assay are (1) the reaction catalyzed by argininosuccinate synthetase 
citrulline + aspartate + ATP + MgC12 ~ argininosuccinate + AMP + PPi 
and (2) the utilization of argininosuccinate by argininosuccinate lyase in the 
reaction 
argininosuccinate--, fumarate + arginine 
No inhibitor specific for argininosuccinate lyase was added because none is 
known other than the antibody (Bray and Rather, 1971; Rather, 1955). So 
little 14C-argininosuccinate accumulates under the conditions of the assay 
that argininosuccinate lyase is not saturated with respect to its substrate, and 
therefore the rate of degradation of argininosuccinate is negligible. Our assay 
has the advantages that it is technically easy to do, requires very little material 
(only 0.1 mg cell lysate corresponding to 3 x 105 washed cells is used per assay), 
and is sensitive, easily measuring as little as 2 nmoles per hour per milligram of 
protein. 
MATERIALS AND METHODS 
[U-14C]L-Aspartic acid was purchased from Amersham/Searle in a de- 
oxygenated solution containing 2% ethanol. The specific activity was 224 
mCi per mmole. A minor impurity, constituting 0.4~ of any given aliquot, 
eluted from the Dowex l-X8 acetate column in the same position (the void 
volume) as the product we were monitoring. This impurity gave an undesir- 
able high background and therefore we routinely purified the ~4C-aspartate 
before use. The purification procedure reduced the background from 20,000 
cpm to 1500 cpm. Five milliliters of the above 14C-aspartic acid solution con- 
taining 250 #Ci was applied to a 2-ml Dowex l-X8 acetate column equili- 
brated with 0.05 U acetic acid, packed in a 5-ml pipette. Elution was with 
0.05 M acetic acid. The first 60 ml containing about 6 million cpm was dis- 
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carded; the next 100 ml was collected in a round-bottom flask, evaporated 
to dryness at 30 C in a rotary evaporator, and redissolved in 5 ml deionized 
water. After transfer to a glass vial, the purified 14C-aspartate was stored 
frozen. If  the solution was kept at room temperature, a microorganism grew 
in it which degraded all the aspartate within a week. A second passage through 
a 2-ml column did not further reduce the background counts, nor did use of a 
larger column. 
Stock solutions used in the assay were 0.5 M tris-chloride, p H  7.9, 0.5 M 
MgC12, 0.5 M L-aspartate, pH 7.5, and dilutions therefrom, 0.5 M L-citrulline, 
pH 7.5, and dilutions therefrom, and 0.125 M ATP, pH 7.5. These solutions 
were stored frozen in small aliquots at - 2 0  C. Because ATP is unstable, un- 
used portions of once-thawed solutions were discarded. 
Dowex 1-X8, 200-400 mesh chloride form, was purchased from Bio- 
Rad. The resin was converted to the acetate form by the method of  Hirs 
et  al. (1954) except that no precautions were taken to avoid ammonia ad- 
sorption. The resin was washed with water to remove the fines, then washed 
successively with 3 M sodium acetate, water, 0.5 M acetic acid, and lastly 0.05 
M acetic acid. For enzyme assays, 1-ml columns were packed just before use in 
disposable Pasteur pipettes. Once-used resin was discarded. 
Scintillation fluid was made from Packard Co. scintillators by dissolving 
0.10 g dimethyl POPOP and 4.0 g PPO in 1 liter reagent-grade toluene, then 
mixing in 500 ml Triton X-100 (Rohm and Haas Co.). Fifteen milliliters of 
scintillation fluid was used with 1.5 ml aqueous sample, or 10 ml with 1 ml 
aqueous sample. One-minute counts were taken on a Packard Tri-Carb 
liquid scintillation spectrometer model 3320. The counting efficiency 
was 97~ .  
Lymphocyte lines were the same ones described by Spector and Bloom 
(1973) and Spector et al. (1975). University of Michigan long-term lympho- 
cyte line 21 (UM 21) was established from a male patient with citrullinemia. 
One year later, ten single cell clones were isolated. The parent line was 
designated " U M  21"; the ten clones were called "U M 21 clone 1," " U M  21 
clone 2," etc. These lines grew exponentially in arginine-containing medium 
but were unable to survive in citrulline-containing medium. The lines which 
originated from citrullinemic cultures after 1-2 months of continuous incuba- 
tion in citrulline-containing medium were called "variant" lines. The variants 
can grow in either arginine- or citrulline-containing medium but were main- 
tained routinely in medium with 1 mM citrulline in place of arginine. The 
designations were " U M  2l variant," " U M  21 clone 2 variant," etc. The con- 
trol lines tested were UM 1, UM 43, and UM 61 from male donors and UM 
39, UM 55, and UM 56 from female donors. The controls were lymphocyte 
lines derived from people who did not have citrullinemia. All the control lines 
were maintained in Roswell Park Memorial Institute medium 1640 with 1 
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mM arginine or 1 mM citrulline, 20% fetal calf serum, penicillin, and kana- 
mycin. The cells were harvested during logarithmic growth on the fourth day 
after subculturing. Cell viability at this time was about 90~ as determined by 
trypan blue dye exclusion. 
Mycoplasma Testing 
All cell lines were tested for mycoplasma contamination by Dr. Leonard 
Hayflick, Department of Medical Microbiology, Stanford University School 
of Medicine, Stanford, California, and were found negative. As an additional 
precautionary measure, some of the cell lines were also checked by the Insti- 
tute for Medical Research, Camden, New Jersey, and by the University of 
Michigan Hospital, Microbiology Laboratory, and were also found negative. 
Enzyme Assay 
The assay consisted of several distinct steps done on different days: cell 
harvesting, lysis and incubation in the reaction mixture were done on the 
first day, as many as 50 assays being easily done in 1 day; conversion of 
argininosuccinate to the anhydride was allowed to proceed for 2 days (or 
longer if this proved more convenient); the anhydride was separated from 
~4C-aspartate by chromatographing each sample on a 1-ml Dowex l-X8 
acetate column. 
Preparation of Cells 
Ten milliliters of cell suspension, with 6 million cells prior to washing, was 
centrifuged and washed once with 30 ml cold saline. The cell pellet, now 
containing about 3 million cells which is equivalent to 1 mg protein, was 
put on ice until use. This was enough for ten assays. 
Cell Lysis 
The enzyme lost activity rapidly once the cells were lysed; therefore, lysing 
was not done until the moment of assay. Lysis was achieved by suspending 
the cells in 1 ml water, giving a 1 mg/ml solution, and freeze-thawing two times 
in dry ice-methanol. Freeze-thawing was necessary, for it was found that 
omission of this step reduced activity by 50%. Aliquots were immediately 
pipetted into test tubes containing the reaction mixture. Care was taken to 
minimize the time which elapsed between additions of a given cell lysate to a 
series of test tubes. One-tenth milliliter of lysate was reserved for protein 
determination by the Lowry method. 
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The Reaction 
The reaction mixture contained--in a total volume of 0.5 ml--10 mM tris-C1, 
10 mM MgC12, 100 or 20 mM L-citrulline, 0.2 mM L-aspartate, 5 mM ATP, 
5 million cpm of l~C-aspartate, and 0.1 mg crude cell lysate. The pH of this 
mixture when measured at room temperature was 7.5. The reaction was 
initiated by the addition of cell lysate. After a 1-br incubation at 37 C, the 
reaction was stopped by placing the tubes in a boiling water bath for 5 min. 
Conversion to Anhydride 
To the boiled tubes, 0.05 ml of 1 M acetic acid was added. The contents were 
mixed in a Vortex stirrer and then incubated for 2 days in a 37 C water bath. 
This procedure converted argininosuccinate to the anhydride. 
Chromatography 
Just before use, ten disposable Pasteur pipettes plugged with glass wool were 
packed with equilibrated Dowex l-X8 acetate resin to a height of  4 cm, to 
give 1-ml columns. The entire sample from one test tube, including the de- 
natured protein, was applied to a column and collected directly into a 
scintillation vial. The test tube was rinsed with 1 ml of 0.05 M acetic acid, and 
the rinse was applied to the same column and collected into the same vial. A 
second vial received the next 1.5 ml of 0.05 ~ acetic acid eluate. In these first 
two fractions, 99-99.5% of the anhydride eluted. 
Specific Activity 
Enzyme activity was expressed as nanomoles argininosuccinate produced per 
hour per milligram of protein where protein concentration was measured by 
the Lowry method. 
RESULTS 
Argininosuccinate Synthetase Activity in Cultured Lymphocytes 
Argininosuccinate synthetase activity was measured in the citrullinemic cell 
line, in the nutritional variants, and in several control lines (Table I). The 
apparent Km for citrulline was measured by holding two substrates, ATP and 
aspartate, at saturating concentrations while citrulline concentration was 
varied over a range well below and above K m. Figure la,b shows that ob- 
served activity increased linearly with increasing citrulline concentration 
300, 
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Table I. Argininosuccinate Synthetase Activity in Cultured Lymphocytes 
Specific activity a Specific activity" Apparent Number of 
Cell line at 20 mM Cit at 100 mM Cit K,, times assayed 
Control 15.7 + 8.7 12.5 + 5.1 2 x 10 -~ M 84 
Citrullinemic 0 0 - -  41 
Variant 4.9+2.0 10.7+3.8 2 x  10 - 2  M 27 
Mouse 646 + 103 4 x 10- 4 M 8 
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Fig. 1. Determination of apparent K,,'s for citrulline of argininosuccinate synthetase in 
various lymphocyte lines. (a) Results for control lines. D, UM 21 clone 6 grown in citrul- 
line; e,  UM 43 grown in citrulline; A, UM 21 clone 6 grown in arginine; o, UM 43 grown 
in arginine. (b) Results for variant lines, e,  UM 21 parent variant; [], UM 21 clone 5 
variant; ©, UM 21 clone 2 variant; A, UM 21 clone 3 variant. 
and  tha t  the cont ro l  lines were sa tura ted  with respect  to ci trul l ine at  20 mM 
citrull ine while the var iants  were sa tura ted  at  100 mM citrulline.  The specific 
activities at  these citrull ine concentra t ions  are  therefore  an a pp rox ima t ion  
o f  max imal  veloci ty (Vmax). They deviate  f rom Vma x mainly  because the in- 
cuba t ions  were for  1 hr, and  Fig.  2 shows tha t  the reac t ion  rates had  fal len 
off by  abou t  1 5 ~  at  1 hr. Table  I shows tha t  c i t rul l inemic lymphocytes  had  
no argininosuccinate  synthetase act ivi ty whatsoever .  N o  act ivi ty was detected 
even when the assay was run  with the very high citrull ine concent ra t ion  o f  
0.3M. 
Of  the ten clones,  only  one, clone 6, had  activity,  and  this act ivi ty was 
no rma l  bo th  in K,, and  specific activity.  This except ional  clone was cons idered  
to  be no rma l  and  no t  ci trull inemic.  Clone 6 was no rma l  by  other  cr i ter ia :  i t  
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Fig. 2. Argininosuccinate synthetase 
activity as a function of incubation time. 
Argininosuccinate synthetase activity 
was measured as described in Materials 
and Methods except that the total 
volume of reaction mixture was 3.5 ml. 
At the indicated time intervals, 0.5 ml 
was removed and placed in a boiling 
water bath to stop the reaction. 
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grew in citrulline-containing medium without undergoing the weeks of lag 
typical for the other clones; it took up 14C-citrulline from the medium and 
incorporated it into protein arginine at the same rate as did normal cells 
(Spector et al., 1975). 
Argininosuccinate synthetase in all control lines had an apparent K,, for 
citrulline of  2 x 10 .4  M. The K,, value was an extremely reliable, reproducible 
number. K,, was a better criterion for distinguishing control cells f rom variant 
cells than was specific activity, for, as Table I shows, the maximum specific 
activities for these cells were similar. Measurement of  specific activity was an 
excellent method, however, to distinguish citrullinemic cells f rom all other 
cells, for the citrullinemic cells had zero activity. 
Arginosuccinate synthetase in the variant lines typically had a much 
higher apparent Km for citrulline than in control lines. The variant K,,,s 
probably were not all an identical 2 x 10 -a  M; in fact, it is much more likely 
that if each variant line is the result of a different independent mutation the 
Km will differ slightly for each line. Because we were assaying crude homo- 
genates, we did not have confidence in the small observed differences and 
therefore do not report them. Fresh lymphocytes from freshly drawn human 
blood had no activity. 
Enzyme Assay Method 
Linear Relationship Between Amount of Cell Lysate Used in Assay and Specific 
Activity 
Since argininosuccinate is an intermediate in the urea cycle, it was important  
to choose conditions minimizing its degradation by argininosuccinate lyase. 
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Fig. 3. Range of linearity between mg cell 
lysate used in assay and cpm in product. 
The assay is linear up to about 0.15 nag 
cell lysate. Line UM 1-6TG is line UM 1 
selected for growth in 6-thioguanine. 
High concentrations of  cell lysate would be expected to rapidly form as well 
as degrade argininosuccinate. Low concentrations of  cell lysate would con- 
tain so little synthetase and lyase that it would be possible to saturate the 
synthetase with substrate without producing enough argininosuccinate for 
the very dilute lyase to encounter at a significant frequency. At low cell 
lysate concentrations, one could expect to find the amount  of  argininosuc- 
cinate isolated to be linearly related to the amount  of  cell lysate used in the 
assay. The experimental findings were as predicted (Fig. 3), showing a linear 
relationship when 0.025-0.15 mg was used per assay, and a definite decline 
with 0.3 mg or more. The optimal amount  of  protein per assay was found to 
be 0.1 mg. 
In order to show that loss of argininosuccinate through action of  arginino- 
succinate lyase was negligible, we measured 14C-fumarate, 14C-malate, and 
carbon dioxide. The label from argininosuccinate can go into fumarate and 
hence, through the citric acid cycle, into malate and carbon dioxide. We 
found negligible amounts of  fumarate but did find malate and carbon di- 
oxide when high concentrations of  cell lysate were used or when an exception- 
ally active cell line such as the mouse line was assayed. These extremes 
defined the limits of our assay; one could not use as much as 0.4 mg cell 
lysate per assay (the best amount  to use is 0.1 rag) and the product should 
contain not more than about 100,000 cpm, i.e., 0.004 raM. Under the con- 
ditions described in Materials and Methods, the loss of argininosuccinate 
through the action of lyase was negligible. 
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Table II. Dependence of Argininosuccinate 
Formation on Added Citrulline" 
Assay Cpm in product 
Complete 135,417 
No citrulline 0 
No ATP 12,344 
No cell lysate 0 
"Lysate from the control line UM 43 was 
used. 
Dependence of Argininosuccinate Formation on Added Citrulline 
Because aspartate may potentially be metabolized into about 18 different 
compounds by entering the pyrimidine biosynthetic pathway and the citric 
acid cycle, it was important to prove that the radioactive compound with the 
characteristic elution properties of argininosuccinate was indeed arginino- 
succinate. This was done by measuring the dependence of formation of this 
compound on the presence of citrulline and of ATP. Table II shows that there 
is an absolute dependence on added citrulline for the formation of arginino- 
succinate. This confirms the identity of the compound, for orotic acid and 
other intermediates of pyrimidine biosynthesis would still have been made 
in the absence of added citrulline. That our product is not one of the citric 
acid cycle intermediates is demonstrated by the fact that the latter are all 
(with the exception of succinyl CoA) di- and tricarboxylic acids and there- 
fore would elute after aspartic acid rather than before it. In the absence of 
added ATP, some product was still formed, probably reflecting the presence 
of endogenous ATP. Another proof of identity is the fact that the assay 
product cochromatographed with commercial argininosuccinate, as well as 
with ~4C-argininosuccinate made enzymatically with purified beef liver 
argininosuccinate synthetase. 
Anhydride Formation 
We decided to convert argininosuccinate to anhydride because some of the 
product in every reaction spontaneously converted to anhydride, necessitating 
inclusion of this peak in the total product counts, and because the anhydride 
eluted in a much smaller volume than did the acid, thus increasing the sensi- 
tivity of the assay. Complete conversion of argininosuccinate to anhydride 
was obtained by adding 0.05 ml 1 M acetic acid to the boiled 0.5 ml reaction 
mixture and incubating at 37 C for 2 days. If any argininosuccinate had 
remained in the acid form, it would have eluted immediately after the an- 
hydride in the position shown in Fig. 4. 
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Fig. 4. Separation of argininosuccinate anhydride 
from L-aspartate on a 1-ml column. A 1-ml Dowex 
1-X8 acetate column was used to separate arginino- 
succinate anhydride from unreacted aspartate in a 
typical reaction mixture containing all the reactants 
described in Materials and Methods (e). The degree 
of resolution between anhydride and aspartate was 
extremely good, as 99°//00 or more of the anhydride 
eluted in the first 3 ml and aspartate began eluting 
only at 21 ml. In experiments carried out as described 
in Materials and Methods, no unconverted acid is 
present. This fact can be checked by collecting 
additional fractions, for unconverted acid (rn) elutes 
just behind the anhydride. The contribution of the 
impurity in the ~4C-aspartate to the total product 
counts was quantitated by running a control con- 
taining everything but cell lysate (©). 
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Conversion to anhydride might have been accomplished with the same 
efficiency in a much shorter time by boiling an acidified mixture. Ratner 
(1957) showed that, at pH 3.2, 100% conversion to anhydride occurred in 30 
min at 100 C. 
Activi ty  as a Function o f  Incubation Time 
Activity up to 15 min incubation was linear and maximal, but thereafter it 
declined (Fig. 2). A 1-hr incubation gave about 85% of the specific activity 
seen initially. An incubation time of 1 hr was chosen because in many 
instances mutants with very low activities, detection of which was possible 
only with prolonged incubation, were being assayed. 
Enzyme Stability 
Activity was rapidly lost when cells, lysed with water and two freeze-thawings, 
were kept at 37 C. The half-life at 37 C in water was about 2 min. On the 
other hand, the enzyme was quite stable in the assay mixture at 37 C, a 1-hr 
incubation giving 85% of the specific activity observed in a 5- or 15-min in- 
cubation. Such a rapid loss of activity would have made it impossible to carry 
out meaningful activity assays were it not for the finding that at 0 C the 
enzyme was stable. If the freeze-thawed cells were immediately put on ice, 
they maintained a constant activity over the time required to pipette a series 
of tubes. The half-life at 0 C in water was about 1½ hr. 
DISCUSSION 
The finding that our citrullinemic patient's lymphocytes completely lack 
argininosuccinate synthetase activity supports Spector's (Spector and Bloom, 
!973; Spector et al., 1975) earlier observation that these same lymphocytes 
incorporated no 14C-citrulline into 14C-arginine in their protein and that 
they did not grow in medium in which citrulline had been substituted for 
arginine. Only three citrullinemic patients have to date been tested for 
argininosuccinate synthetase activity. Our patient is the only one with zero 
activity. Tedesco and Mellman (1967) found activity in fibroblasts from their 
citrullinemic patient. Kennaway et al. (1975) found activity in fibroblasts 
from yet another patient. Skin fibroblasts from our patient had no arginino- 
succinate synthetase activity (Scott-Emuakpor et aI., 1972; Kennaway et al., 
1975). Kennaway et al. (1975) assayed our citrullinemic lymphocyte line by a 
different method (Schimke, 1964) and also found zero activity. 
Spector et al. (1975) have discussed the origin of the variant lymphocyte 
lines and concluded that they are cells with spontaneous back-mutations to 
partially active argininosuccinate synthetase selected out of the citrullinemic 
population by medium containing citrulline in place of arginine. The fact that 
406 Lockridge, Spector, and Bloom 
variant-type cells were obtained from four clones and that argininosuccinate 
synthetase in them has an altered apparent K m for citrulline compared to 
normal cells is strong evidence that the mutation causing citrullinemia in 
this patient is a structural gene mutation. I f  K,, is interpreted as reflecting 
substrate affinity, then the variant lines have a marked decrease in affinity for 
citrulline. It  is equally likely that the/(ms for ATP and aspartate are altered, 
but these were not measured. 
Assays for argininosuccinate synthetase previously reported in the 
literature are of three types: (1) a colorimetric assay depending on either the 
disappearance of citrulline or the appearance of urea (Archibald, 1945; 
Koritz and Cohen, 1954; Rather, 1955) is much too insensitive to detect 
activity in the very limited amounts of  material present in cell culture; (2) a 
spectrophotometric kinetic assay linked to the utilization of N A D H  (Rather, 
1970) cannot be used for crude cell homogenates because the amount  of 
citrulline-independent N A D H  oxidation present as background is so high 
that the small contribution from argininosuccinate synthetase activity cannot 
be detected; (3) a sensitive radioactive assay suitable for crude homogenates 
depends on the conversion of ~4C-citrulline to ~4C-urea by added excess 
argininosuccinate lyase and arginase (Schimke, 1964). This assay is difficult 
to carry out as there is no commercial source of lyase. The assay described in 
this communication is preferable because it directly measures the product 
of  the enzyme reaction, it can be done with crude cell homogenates requiring 
little cell protein, and it is very sensitive. Kato et al. (1976) have published a 
similar assay for argininosuccinate synthetase in various rat  organs. 
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